155 related articles for article (PubMed ID: 24357267)
21. Thiamine-responsive megaloblastic anemia syndrome.
Bay A; Keskin M; Hizli S; Uygun H; Dai A; Gumruk F
Int J Hematol; 2010 Oct; 92(3):524-6. PubMed ID: 20835854
[TBL] [Abstract][Full Text] [Related]
22. Recurrent psychiatric manifestations in thiamine-responsive megaloblastic anemia syndrome due to a novel mutation c.63_71 delACCGCTC in the gene SLC19A2.
Wood MC; Tsiouris JA; Velinov M
Psychiatry Clin Neurosci; 2014 Jun; 68(6):487. PubMed ID: 24520986
[No Abstract] [Full Text] [Related]
23. Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.
Ghaemi N; Ghahraman M; Abbaszadegan MR; Baradaran-Heravi A; Vakili R
J Clin Res Pediatr Endocrinol; 2013 Sep; 5(3):199-201. PubMed ID: 24072090
[TBL] [Abstract][Full Text] [Related]
24. Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
Wu S; Yuan Z; Sun Z; Yao F; Sui R
Am J Med Genet A; 2022 Mar; 188(3):948-952. PubMed ID: 34821467
[TBL] [Abstract][Full Text] [Related]
25. Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
Khurshid A; Fatimah S; Altaf C; Malik HS; Sajjad Z; Khadim MT
J Coll Physicians Surg Pak; 2018 Sep; 28(9):S169-S171. PubMed ID: 30173687
[TBL] [Abstract][Full Text] [Related]
26. A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
Yeşilkaya E; Bideci A; Temizkan M; Kaya Z; Camurdan O; Koç A; Bozkaya D; Koçak U; Cinaz P
J Trop Pediatr; 2009 Aug; 55(4):265-7. PubMed ID: 18614593
[TBL] [Abstract][Full Text] [Related]
27. The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.
Enogieru OJ; Koleske ML; Vora B; Ngo H; Yee SW; Chatad D; Sirota M; Giacomini KM
AAPS J; 2021 Mar; 23(2):35. PubMed ID: 33649974
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G
Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
Habeb AM; Flanagan SE; Zulali MA; Abdullah MA; Pomahačová R; Boyadzhiev V; Colindres LE; Godoy GV; Vasanthi T; Al Saif R; Setoodeh A; Haghighi A; Haghighi A; Shaalan Y; ; Hattersley AT; Ellard S; De Franco E
Diabetologia; 2018 May; 61(5):1027-1036. PubMed ID: 29450569
[TBL] [Abstract][Full Text] [Related]
30. Cochlear implant and thiamine-responsive megaloblastic anemia syndrome.
Hagr AA
Ann Saudi Med; 2014; 34(1):78-80. PubMed ID: 24658560
[TBL] [Abstract][Full Text] [Related]
31. Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.
Jungtrakoon P; Shirakawa J; Buranasupkajorn P; Gupta MK; De Jesus DF; Pezzolesi MG; Panya A; Hastings T; Chanprasert C; Mendonca C; Kulkarni RN; Doria A
Diabetes; 2019 May; 68(5):1084-1093. PubMed ID: 30833467
[TBL] [Abstract][Full Text] [Related]
32. Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia.
Bouyahia O; Ouderni M; Ben Mansour F; Matoussi N; Khaldi F
Ann Endocrinol (Paris); 2009 Dec; 70(6):477-9. PubMed ID: 19922902
[TBL] [Abstract][Full Text] [Related]
33. Thiamine responsive megaloblastic anemia: the puzzling phenotype.
Beshlawi I; Al Zadjali S; Bashir W; Elshinawy M; Alrawas A; Wali Y
Pediatr Blood Cancer; 2014 Mar; 61(3):528-31. PubMed ID: 24249281
[TBL] [Abstract][Full Text] [Related]
34. An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome.
Kutlucan A
J Coll Physicians Surg Pak; 2019 Jun; 29(6):S13-S15. PubMed ID: 31142407
[TBL] [Abstract][Full Text] [Related]
35. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
Olsen BS; Hahnemann JM; Schwartz M; Østergaard E
Pediatr Diabetes; 2007 Aug; 8(4):239-41. PubMed ID: 17659067
[TBL] [Abstract][Full Text] [Related]
36. Pancytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Moulin V; Grandoni F; Castioni J; Lu H
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29903777
[TBL] [Abstract][Full Text] [Related]
37. Thiamine responsive megaloblastic anemia in three Indian children.
Raju K N Gowda V; Shivananda GM; Sankhyan N
Indian J Pediatr; 2011 Jul; 78(7):888-9. PubMed ID: 21340725
[No Abstract] [Full Text] [Related]
38. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
[TBL] [Abstract][Full Text] [Related]
39. Arrhythmia in thiamine responsive megaloblastic anemia syndrome.
Argun M; Baykan A; Hatipoğlu N; Akın L; Şahin Y; Narin N; Kurtoğlu S
Turk J Pediatr; 2018; 60(3):348-351. PubMed ID: 30511554
[TBL] [Abstract][Full Text] [Related]
40. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
